Mankind Pharma reports Q2FY26 earnings

Mankind Pharma reports Q2FY26 earnings. The company has released its financial results for the quarter ended September 30, 2026. Key metrics include revenue of ₹1,842 crore and net profit of ₹312 crore, showing 12% YoY growth in profitability. Results reflect sustained performance in core generics and consumer health segments.

📊 STOCKS: $MANKIND | 🏢 SECTOR: Pharma | #HIGHIMPACT #Earnings